Growyoung
Lycopene contains 12 mg of Lycopene and alpha and beta carotene. Lycopen
is a strong anti-oxidant. According to the studies, It
could reduce the risk of prostate cancer by 34%. For more
information of cancer and
anti-oxidants and prostate
cancer, check here. It
has been found a higher blood lycopene levels
in men can low risk of prostate cancer. Men who
consumed tomato sauce two to four times a week had a 34
percent lower risk of prostate cancer than men who ate no
tomato sauce.
- Lycopene represents one of the central molecules in the
synthesis of carotenoids, giving rise tobeta-carotene and
other carotenoids through a series of biochemical
reactions. The compound's chemical structure accounts for
its most important biologic activity, that of quenching
singlet oxygen and preventing oxidative damage to other
molecules and cellular structures.
With 11 conjugated double bonds and no cyclic
groups, Iycopene is among the most efficient antioxidants
of the carotenoids.
Direction:
Take 1 capsules with water, 1 - 2 times per day.
·
Keep out of reach of children.
·
Do not use if seal is broken or missing.
·
Protect from heat, light and moisture.
These statements have not been evaluated by the Food
and Drug Administration. This product is not
intended to diagnose, treat, cure or prevent any
disease
|
- Supplement Facts
-
- Serving Size: One Capsule
-
Amount Per Serving
% Daily Value
-
- Lycopene
12mg **
- Alpha-carotene
0.5 mg
33.4%
- Beta-carotene
1 mg
66.8%
- Citrus Bioflavonoids 100 mg **
- (Standardized to 10% )
-
- Ingredients: Carrot Concentrate, Lycopene, Citrus
- Bioflavonoids, Silicon Dioxide, Magnesium Stearate,
- Gelatin.
- ** Daily
Value not established.
-
- Reseal tightly after opening and
keep in dry place.
-
-
- The past decade has
witnessed the emergence of Iycopene from being considered
a "physiologically inert" compound, to one
generating a plethora of research and gaining recognition
for its unique characteristics among the carotenoids,
themselves the subject of numerous intriguing studies
concerning nutrition and health. Early investigators
virtually ignored Iycopene in favor of its carotenoid
relatives, many of which unlike Iycopene, possess
provitamin A activity, and described the compound as
merely an "adventitious visitor to the body".
Scientists now recognize that Iycopene's lack of
provitamin A activity, may in itself increase the
compound's potential health value by making more available
for antioxidant and other beneficial biologic activities.
Even so, a decade is a relatively brief span of time for
research efforts to yield detailed descriptions of
mechanism and action, and briefer still to yield useable
data upon which public health recommendations can be made.
But as national experts have recently identified
phytochemicals as significant compounds, deserving of
guidelines for recommended intakes, interest can only be
expected to flourish. Especially intriguing is the notion
of tissue-specific functionality, a logical extension of
data showing extraordinarily high oncentrations in the
adrenals, testes, and prostate. With the possibility of
targeted health benefits, for instance, there could be a
link between high tissue Iycopene levels and the observed
inverse relation of Iycopene intake and prostate cancer
risk. Perhaps equally as fascinating is the possfbility
that Iycopene, in concert with other carotenoids, and
indeed with other antioxidant nutrients and phytochemicals
in foods, generate a potent interactive network crucial to
the body's establishment and maintenance of an optimally
effective defense system against a host of oxidatively
influenced disease processes.
- Compelling evidence from a
diverse body of carotenoid research points to these
compounds, with Iycopene currently at the forefront, for
an expanding role in health and disease prevention, an
increasingly crucial area for the aging American
population for which the incidence of chronic diseases is
expected to increase dramatically in the coming decades.
This focus on disease prevention will be
particularly pivotal since current treatment modalities
for cancer and cardiovascular disease are costly and often
ineffective. As researchers plumb the mysteries of this
intriguing and promising compound, their discoveries will
guide dietary recommendations for Iycopene and other
carotenoids and the potential efficacy of supplementation.
- References
- 1. Reigh, P, Shwaghman, H,
Craig, JM. 1960. N Eng J Med. 262:263-269
- 2. Krinsky, NI. 1993. Ann
Rev Nutr. 13:561-587
- 3. Krinsky, NI. 1992. Proc
Soc Exp Bioi Med. 200:248-254
- 4. Block, G, Patterson, B,
Subar, A. 1992. Nutr Cancer. 18:1-29
- 5. Buiatti, E, Palli, 0,
Decarli, A, Amadori, 0, Avellini, C, Bianchi, S, Biserni,
R, Cipriani, F; Cocco, P, Giacosa, A, Marubini, E, Puntoni,
R, Vindigni, C, Fraumeni, J,
- Blot, W. 1989. Int J
Cancer. 44:611-616
- 6. Mills, PK, Beeson, L,
Phillips, RL, Fraser, GE. 1989. Cancer. 64:598-604
- 7. Giovanucci, E, Ascherio,
A, Rimm, EB, Stampfer, MJ, Colditz, GA, Willet, WC. 1995.
J Natl Cancer Inst.87:1767-1776
- 8. Norum, KR, Blomhoff, R.
1992. Am J Clin Nutr. 56:735-744
- 9. Mangelsdorf, OJ,
Umesono, K, Evans, RM. 1994. In: The Retinoids: Biology,
Chemistry, and Medicine. 2nd ed. pp 319-349. New York, NY:
Raven Press
- 10. Bendich, A, Olson, JA.
1989. FASEB J. 3:1927-1932
- 11. Rock, CL, Kusluski,
RA, Galvez, MM, Ethier, SP. 1995. Nutr Cancer. 23:319-333
- 12. Bendich, A. 1994. Pure
Appl Chern. 66:1017-1024
- 13. Zhang, LX, Cooney,RV,
Bertram, JS. 1991. Carcinogenesis. 12:2109-2114
- 14. Erdman, JW, Bierer,
TL, Gugger, ET. 1993. Ann N Y Acad Sci. 691:76-85
- 15. Bowen, PE, Mobarhan,
S, Smith, JC. 1993. Methods Enzymol. 214:3-17
-
Price of this item for the Special
wholesale price program click here.
Inquire for the wholesale,
distribution and private labeling of this item click
here,
or check bulk supply to learn more.
| Home
| Nutrition Products | Bio-medical
Research products | News | Nutrition
Supplement List
-
CHS INTERNATIONAL RESEARCH LTD
|
